Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Hepatology. 2011 Oct;54(4):1313–1321. doi: 10.1002/hep.24494

Figure 2.

Figure 2

Mortality for transplant candidates. Mortality following initial potential donor evaluation for candidates without HCC according to MELD score at evaluation and whether LDLT was performed or not. For graphical purposes, mortality while awaiting LDLT is assumed to be the same as mortality for candidates for whom LDLT was not available up until the median time for LDLT (3.0 months for MELD<15 and 2.5 months for MELD15+). Shown for patient age=50, no HCC, with HCV, no other cholestatic disease, and MELD=10 at enrollment for MELD<15 group and MELD=20 at enrollment for MELD 15+ group.